These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

748 related articles for article (PubMed ID: 20616166)

  • 1. SGLT2 mediates glucose reabsorption in the early proximal tubule.
    Vallon V; Platt KA; Cunard R; Schroth J; Whaley J; Thomson SC; Koepsell H; Rieg T
    J Am Soc Nephrol; 2011 Jan; 22(1):104-12. PubMed ID: 20616166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase in SGLT1-mediated transport explains renal glucose reabsorption during genetic and pharmacological SGLT2 inhibition in euglycemia.
    Rieg T; Masuda T; Gerasimova M; Mayoux E; Platt K; Powell DR; Thomson SC; Koepsell H; Vallon V
    Am J Physiol Renal Physiol; 2014 Jan; 306(2):F188-93. PubMed ID: 24226519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organic anion transporter OAT3 enhances the glucosuric effect of the SGLT2 inhibitor empagliflozin.
    Fu Y; Breljak D; Onishi A; Batz F; Patel R; Huang W; Song P; Freeman B; Mayoux E; Koepsell H; Anzai N; Nigam SK; Sabolic I; Vallon V
    Am J Physiol Renal Physiol; 2018 Aug; 315(2):F386-F394. PubMed ID: 29412698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo expression of sodium-glucose cotransporter SGLT2 in Bowman's capsule coincides with replacement of parietal epithelial cell layer with proximal tubule-like epithelium.
    Tabatabai NM; North PE; Regner KR; Kumar SN; Duris CB; Blodgett AB
    J Membr Biol; 2014 Aug; 247(8):675-83. PubMed ID: 24906870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Na
    Calado J; Santos AR; Aires I; Lebre F; Nolasco F; Rueff J; Ramalho J
    FEBS Lett; 2018 Oct; 592(19):3317-3326. PubMed ID: 30156268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene deletion of the Na
    Nespoux J; Patel R; Hudkins KL; Huang W; Freeman B; Kim YC; Koepsell H; Alpers CE; Vallon V
    Am J Physiol Renal Physiol; 2019 Jun; 316(6):F1201-F1210. PubMed ID: 30995111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SGLT2 inhibition and renal urate excretion: role of luminal glucose, GLUT9, and URAT1.
    Novikov A; Fu Y; Huang W; Freeman B; Patel R; van Ginkel C; Koepsell H; Busslinger M; Onishi A; Nespoux J; Vallon V
    Am J Physiol Renal Physiol; 2019 Jan; 316(1):F173-F185. PubMed ID: 30427222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for tubular Na
    Onishi A; Fu Y; Patel R; Darshi M; Crespo-Masip M; Huang W; Song P; Freeman B; Kim YC; Soleimani M; Sharma K; Thomson SC; Vallon V
    Am J Physiol Renal Physiol; 2020 Oct; 319(4):F712-F728. PubMed ID: 32893663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of sodium/glucose cotransporter inhibition on a rat model of angiotensin II-dependent kidney damage.
    Reyes-Pardo H; Bautista R; Vargas-Robles H; Rios A; Sánchez D; Escalante B
    BMC Nephrol; 2019 Aug; 20(1):292. PubMed ID: 31375080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dapagliflozin Binds Specifically to Sodium-Glucose Cotransporter 2 in the Proximal Renal Tubule.
    Ghezzi C; Yu AS; Hirayama BA; Kepe V; Liu J; Scafoglio C; Powell DR; Huang SC; Satyamurthy N; Barrio JR; Wright EM
    J Am Soc Nephrol; 2017 Mar; 28(3):802-810. PubMed ID: 27620988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of renal tubule-specific knockdown of the Na
    Onishi A; Fu Y; Darshi M; Crespo-Masip M; Huang W; Song P; Patel R; Kim YC; Nespoux J; Freeman B; Soleimani M; Thomson S; Sharma K; Vallon V
    Am J Physiol Renal Physiol; 2019 Aug; 317(2):F419-F434. PubMed ID: 31166707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of an SGLT2-loss of function mutation on renal architecture, histology, and glucose homeostasis.
    Hughes CB; Mussman GM; Ray P; Bunn RC; Cornea V; Thrailkill KM; Fowlkes JL; Popescu I
    Cell Tissue Res; 2021 May; 384(2):527-543. PubMed ID: 33409652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene knockout of the Na
    Nespoux J; Patel R; Zhang H; Huang W; Freeman B; Sanders PW; Kim YC; Vallon V
    Am J Physiol Renal Physiol; 2020 May; 318(5):F1100-F1112. PubMed ID: 32116018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Sweet Pee model for Sglt2 mutation.
    Ly JP; Onay T; Sison K; Sivaskandarajah G; Sabbisetti V; Li L; Bonventre JV; Flenniken A; Paragas N; Barasch JM; Adamson SL; Osborne L; Rossant J; Schnermann J; Quaggin SE
    J Am Soc Nephrol; 2011 Jan; 22(1):113-23. PubMed ID: 21209254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probing SGLT2 as a therapeutic target for diabetes: basic physiology and consequences.
    Gallo LA; Wright EM; Vallon V
    Diab Vasc Dis Res; 2015 Mar; 12(2):78-89. PubMed ID: 25616707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting renal glucose reabsorption to treat hyperglycaemia: the pleiotropic effects of SGLT2 inhibition.
    Vallon V; Thomson SC
    Diabetologia; 2017 Feb; 60(2):215-225. PubMed ID: 27878313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Na+-D-glucose cotransporter SGLT2 in rodents is kidney-specific and exhibits sex and species differences.
    Sabolic I; Vrhovac I; Eror DB; Gerasimova M; Rose M; Breljak D; Ljubojevic M; Brzica H; Sebastiani A; Thal SC; Sauvant C; Kipp H; Vallon V; Koepsell H
    Am J Physiol Cell Physiol; 2012 Apr; 302(8):C1174-88. PubMed ID: 22262063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel frame-shift mutation in Slc5a2 encoding SGLT2 in a strain of senescence-accelerated mouse SAMP10.
    Unno K; Yamamoto H; Toda M; Hagiwara S; Iguchi K; Hoshino M; Takabayashi F; Hasegawa-Ishii S; Shimada A; Hosokawa M; Higuchi K; Mori M
    Biochem Biophys Res Commun; 2014 Nov; 454(1):89-94. PubMed ID: 25450362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental type II diabetes and related models of impaired glucose metabolism differentially regulate glucose transporters at the proximal tubule brush border membrane.
    Chichger H; Cleasby ME; Srai SK; Unwin RJ; Debnam ES; Marks J
    Exp Physiol; 2016 Jun; 101(6):731-42. PubMed ID: 27164183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium-glucose transporter-2 (SGLT2; SLC5A2) enhances cellular uptake of aminoglycosides.
    Jiang M; Wang Q; Karasawa T; Koo JW; Li H; Steyger PS
    PLoS One; 2014; 9(9):e108941. PubMed ID: 25268124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.